semaglutide

Patients

woman holds her lower abdomen in discomfort

Beyond weight loss: Exploring the impact of weight loss medi...

It’s been less than two years since weight loss medications Wegovy and Mounjaro were approved in the UK to treat obesity.

News

ACC25: Ozempic shows its value in PAD

Novo Nordisk's Ozempic has been shown to improve walking distance in people with diabetes and peripheral artery disease in the STRIDE trial.

Market Access

Therapeutic or cosmetic? Patent strategies for dual-use inno...

In the pharmaceutical and cosmetic sectors, innovation often stems from discovering new applications for known compounds.

News

Compounders cast adrift after semaglutide shortage ends

The FDA has said there is no longer a shortage in the US market for Novo Nordisk's GLP-1 agonist semaglutide, ending sales of compounded forms.

News

Small study finds GLP-1 drug can curb excess alcohol use

Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder.

News

Pharma group slams Hims & Hers over Super Bowl GLP-1 ad

Partnership for Safe Medicines claims the Hims & Hers ad for compounded weight-loss drug semaglutide, due to run during the Super Bowl, is "reckless."

Beyond weight loss: Exploring the impact of weight loss medi...

ACC25: Ozempic shows its value in PAD

Therapeutic or cosmetic? Patent strategies for dual-use inno...

Compounders cast adrift after semaglutide shortage ends

Small study finds GLP-1 drug can curb excess alcohol use

Pharma group slams Hims & Hers over Super Bowl GLP-1 ad

CHMP backs Novo's haemophilia A drug Frehemgo

Discover a new era of healthcare panel engagement: Grounded ...

semaglutide

Editor's Picks